Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1993
12/18/1993CA2098366A1 Substituted (benzothiazolyl- and quinoxalyl-methoxy) phenyl-acetic acid derivatives
12/17/1993CA2098410A1 Pharmaceutical soft capsules containing lysine clonixinate and a process for their preparation
12/15/1993EP0574318A1 New process for the preparation of 16-alpha-methyl-steroids
12/15/1993EP0574255A1 New derivatives of non-steroidal anti-inflammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them
12/15/1993EP0573603A1 Inhibitors of human neutrophil elastase and human cathepsin g
12/15/1993EP0573584A1 Method of treating pulmonary inflammation
12/14/1993US5270331 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
12/14/1993US5270324 Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
12/14/1993US5270047 Local delivery of dipyridamole for the treatment of proliferative diseases
12/12/1993CA2098168A1 Hydroxamic acid derivatives
12/12/1993CA2098158A1 Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
12/12/1993CA2096266A1 Method for the prophylaxis and/or treatment of ulceractive gastrointestinal conditions using a potassium activator and compositions for same
12/09/1993WO1993024614A1 Antibodies with specificity for multiple adhesion molecules
12/09/1993WO1993024527A1 Peptide inhibitors of selectin binding
12/09/1993WO1993024526A1 Peptide inhibitors of selectin binding
12/09/1993WO1993024521A1 Bpc peptides, their preparation and use
12/09/1993WO1993024519A1 Lactam dipeptides having hle inhibiting activity
12/09/1993WO1993024513A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof
12/09/1993WO1993024505A1 Reducing inflammation by time dependent administration of oligosaccharides glycosides related to blood group determinants
12/09/1993WO1993024500A1 Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024499A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024498A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
12/09/1993WO1993024497A1 Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024496A1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024494A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024492A1 Spiro-oxetanes, process for preparing the same and medicaments
12/09/1993WO1993024491A1 Indolocarbazole imides and their use
12/09/1993WO1993024475A1 Sulphamide derivatives as metalloproteinase inhibitors
12/09/1993WO1993024473A1 7-(2-aminoethyl)-benzothiazolones
12/09/1993WO1993024449A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
12/09/1993WO1993024143A1 A method for using lipoprotein associated coagulation inhibitor to treat sepsis
12/09/1993WO1993024142A1 New pharmaceutical uses of krill enzymes
12/09/1993WO1993024139A1 Antibiotic cryptdin peptides and methods of their use
12/09/1993WO1993024137A1 Anti-inflammatory agent
12/09/1993WO1993024134A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
12/09/1993WO1993024131A1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024115A1 Anti-rheumatoid arthritic drugs in the treatment of dementia
12/09/1993WO1993024114A1 Reservoir-type plaster containing ketorolac
12/09/1993WO1993014750A3 Amino acids useful as inhibitors of the advanced glycosylation of proteins
12/09/1993DE4218096A1 Spiro-oxetane, Verfahren zu ihrer Herstellung und Arzneimittel Spiro-oxetanes, processes for their preparation and pharmaceutical
12/09/1993CA2306952A1 Method for removing dental plaque
12/09/1993CA2136844A1 Peptide inhibitors of selectin binding
12/09/1993CA2136819A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
12/09/1993CA2136646A1 Anti-inflammatory agent
12/09/1993CA2136619A1 Amide derivatives
12/09/1993CA2136428A1 Peptide inhibitors of selectin binding
12/09/1993CA2136349A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
12/09/1993CA2136183A1 Spiro-oxetanes, processes for their production and pharmaceutical agents
12/09/1993CA2135194A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof
12/09/1993CA2118522A1 Time dependent administration of oligosaccharides glycosides related to blood group determinants having a type i or type ii core structure in reducing inflammation in a sensitizedmammal arising from exposure to an antigen
12/09/1993CA2114623A1 Sulphamide derivatives as metalloproteinase inhibitors
12/09/1993CA2114622A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
12/08/1993EP0573392A1 Thiosemicarbazones derivatives and their use as pharmaceuticals
12/08/1993EP0573391A1 Thiosemicarbazonic acid esters and their use as pharmaceuticals
12/08/1993EP0573318A1 Phenyl carboxamide isoxazole derivatives and salts, process for their preparation and the new intermediates thereof. Their use as pharmaceuticals and pharmaceutical compositions containing them
12/08/1993EP0572922A1 Synergistic combinations comprising lipoic acid and vitamines in medicaments
12/08/1993EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy
12/08/1993EP0572627A1 Solvent system to be enclosed in capsules.
12/08/1993EP0572451A1 Novel steroid esters
12/08/1993CN1079219A Arylacetamides
12/08/1993CN1079216A Chemical compounds
12/07/1993CA2013799C N-alkenylbenzo(b) thieno-(3,2-b) oxazin-2,4-diones
12/04/1993CA2097485A1 Thiosemicarbazone derivatives
12/04/1993CA2097482A1 Thiosemicarbazonic acid esters
12/02/1993DE4217964A1 Indolocarbazol-Imide und deren Verwendung Indolocarbazole imides and the use thereof
12/01/1993EP0572308A2 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them
12/01/1993EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993EP0571502A1 Pmn-derived cr3 modulator and uses thereof
12/01/1993EP0541706A4 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids
11/1993
11/30/1993US5266564 Method for treating certain autoimmune diseases
11/30/1993US5266562 Anti-inflammatory agents
11/26/1993CA2096804A1 Heterocyclic derivatives, method of preparation thereof and pharmaceutical compositions which contain them
11/25/1993WO1993023401A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993WO1993023063A1 Novel neutrophil inhibitors
11/25/1993WO1993023026A1 2-arylpropionic acid compositions and process for preparing the same
11/25/1993WO1993023022A1 Solid dispersion compositions of tebufelone
11/25/1993WO1993023010A1 Ophthalmic compositions containing a cyclosporin
11/25/1993WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993DE4216756A1 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung 2-arylpropionic acid preparations and methods for their preparation
11/25/1993CA2136196A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993CA2135390A1 Novel neutrophil inhibitors
11/24/1993EP0570454A1 Novel steroids
11/24/1993EP0570414A1 Naphthoquinone derivatives for the treatment of chronic inflammation
11/24/1993CN1022832C Preparation of 3-substituted-2-oxindole derivatives
11/23/1993US5264578 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
11/23/1993US5264437 Antiinflammatory agents, immunosuppressants or antiallergens
11/23/1993US5264430 Enzyme inhibitor, antiinflammatory agents, treats emphysema, cystic fibrosis and arthritis
11/23/1993CA1324527C Lipidic emulsion for parenteral or enteral use
11/18/1993EP0570091A1 Anthraquinone derivatives, process for their preparation and their use as medicaments
11/18/1993EP0569802A1 Arylacetamides
11/18/1993EP0569598A1 Benzoxazinone derivative
11/18/1993EP0569493A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
11/18/1993EP0569491A1 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
11/18/1993EP0439549B1 Use of resiniferatoxin and analogues thereof to cause sensory afferent c-fiber and thermoregulatory desensitization
11/17/1993CN1078470A Optionally substituted pyrido |2,3-d¨ pyrimidine-2,4(1H,3H)-diones and pyrido |2,3-d¨ pyrimidine-2(1H,3H)-ones
11/17/1993CN1022754C Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds preparation method
11/16/1993US5262565 Naphthalene derivatives
11/16/1993US5262423 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
11/16/1993US5262419 Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
11/16/1993US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
1 ... 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 ... 1272